Anest. intenziv. Med. 2009;20(4):176-184

iNO in acute respiratory failure of the newborns. A comparison of its combination with CMV and HFOVIntensive Care Medicine - Original Paper

Lukáš Marek1,*, Vobruba Václav2, Košut Peter1, Srnský Pavel2, Žurek Jiří1, Koudelková Ludmila1, Košinová Lucie1, Fedora Michal1
1 Klinika dětské anesteziologie a resuscitace Lékařské fakulty Masarykovy univerzity a Fakultní nemocnice Brno
2 Jednotka intenzivní a resuscitační péče Kliniky dětského a dorostového lékařství Všeobecné fakultní nemocnice v Praze

Objective:
To compare the effect of inhaled nitric oxide (iNO) combined with conventional mechanical ventilation (CMV) or high-frequency oscillatory ventilation (HFOV) on oxygenation and ventilation parameters, complications rates and mortality in newborns with acute hypoxic respiratory failure (AHRF).

Design:
A prospective observational study.


Setting:
The Paediatric Anaesthesia and Intensive Care Clinic, University Hospital Brno, and The Paediatric and Adolescent Medicine Clinic, General University Hospital, Prague.

Materials and methods:
We enrolled in the study newborns with persistent pulmonary hypertension (PPHN) or acute respiratory distress syndrome (ARDS) without congenital heart disease in whom CMV or HFOV had failed. The newborns were divided in the CMV or HFOV groups according to the type of ventilation during iNO therapy. We recorded the following characteristics: the demographic data, duration of hospitalization, mechanical ventilation and iNO therapy, ARDS origin, diagnosis, outcome, iNO concentration; oxygenation, ventilation and acid-base parameters, ventilator settings and complications due to iNO.

Results:
We enrolled 25 newborns. We recorded a temporary improvement in oxygenation in both the groups and in particular in the HFOV group. We did not record any improvement in the ventilation and acid-base parameters. We did not observe an effect on the ventilator settings except for a comparable decrease of FiO2 in both the groups. We did not record any adverse effects. Total mortality was 4%.

Conclusion:
Both the therapeutic combinations improve oxygenation in the newborns with AHRF. HFOV has an additive effect on oxygenation. Either combination did not influence the ventilation or acid-base parameters. Both the methods provided for a similar reduction of FiO2 with no effect on the other ventilator settings. We observed the same low probability of adverse effects of administering iNO up to 20 ppm in both combinations. Either combination did not influence the mortality in neonates with AHRF.

Keywords: nitric oxide; newborns; Acute Respiratory Failure; oxygenation; Conventional Mechanical Ventilation; High Frequency Oscilatory Ventilation

Received: November 20, 2008; Accepted: May 16, 2009; Published: August 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marek L, Vobruba V, Košut P, Srnský P, Žurek J, Koudelková L, et al.. iNO in acute respiratory failure of the newborns. A comparison of its combination with CMV and HFOV. Anest. intenziv. Med. 2009;20(4):176-184.
Download citation

References

  1. Roberts, J. D., Polaner, D. M., Lang, P., Zapol, W. M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet, 1992, 3, 340, 8823, p. 818-819. Go to original source... Go to PubMed...
  2. Rossaint, R., Falke, K. J., López, F., Slama, K., Pison, U., Zapol, W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med., 1993, 11, 328, 6, p. 399-405. Go to original source... Go to PubMed...
  3. Sokol, J., Jacobs, S. E., Bohn, D. Inhaled nitric oxide for acute hypoxic respiratory failure in children and adults: a meta-analysis. Anesth. Analg., 2003, 97, 4, p. 989-998. Review. Go to original source... Go to PubMed...
  4. Macese, D., Field, D., Mercier, J. C., Miller, J. et al. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med., 2004, 30, p. 372-380. Go to original source... Go to PubMed...
  5. Loskote, A. U., Kastle, R. A., Hoo, A. F., Lum, S., Ranganathan, S. C., Mok, Q. Q., Stocks, J. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension. Pediatr. Pulmonol., 2008, 43, 3, p. 224-235. Go to original source... Go to PubMed...
  6. Skýtsky, A. S. et al. ACCP Consensus Conference: mechanical ventilation. Intensive Care Med., 1994, 20, p. 64-79. Go to original source... Go to PubMed...
  7. Fedora, M. Vliv terapeutického protokolu na mortalitu syndromu akutní respirační tísně v dětském věku. Habilitační práce, 2005, LF MU Brno, p. 44-47.
  8. Cockburn, F., Cooke, R. W. I., Gamsu, H. R., Greenough, A., Hopkána, A., Macintosh, N., Ogstont, S. A., Parry, G. J., Silverman, M., Shaw, J. C. L., Tarnow-Mordi, W. O., Wilkinson, A. R. CRIB investigators' Group and writing committee: The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet, 1993, 342, p. 193-198. Go to original source...
  9. Wessel, D. L., Adatia, I., Van Marter, L. J., Thompson, J. E., Kane, J. W., Stark, A. R., Kourembanas, S. Improved Oxygenation in a Randomized Trial of Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn. Pediatrics, 1997, 100, 5, p. E7. Go to original source... Go to PubMed...
  10. Davidson, D., Barefield, E. S., Kattwinkel, J., Dudel, G., Damask, M., Straube, R., Rhines, J., Chány, C. T. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics, 1998, 101, 3 Pt 1, p. 325-334. Go to original source... Go to PubMed...
  11. Kinsella, J. P., Axman, S. H. Inhaled Nitric Oxide Therapy in Children. Pediatric Respiratory Reviews, 2005, 6, 3, p. 190-198. Review. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.